ADMA Biologics, Inc.ADMANASDAQ

Revenue (LTM)

$510M

+19.6% YoY

Net Income (LTM)

$147M

-25.7% YoY

Free Cash Flow

$28M

Revenue CAGR (5Y)

+58.4%

Marginsimproving

FCF$0.0B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	81	154↑90.4%	258↑67.6%	426↑65.2%	510↑19.6%
Gross Profit	1	35↑2906.4%	89↑152.2%	220↑146.8%	293↑33.3%
Operating Income	-58	-39↑32.6%	22↑155.0%	139↑542.5%	191↑37.7%
Net Income	-72	-66↑8.0%	-28↑57.2%	198↑800.0%	147↓25.7%
EBITDA	-53	-40↑25.6%	5↑113.0%	148↑2784.6%	198↑34.0%
EPS Diluted	-0.61	-0.43↑29.5%	-0.13↑69.8%	0.81↑723.1%	0.60↓25.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	51	87↑69.4%	51↓40.6%	103↑100.9%	88↓15.0%
Total Current Assets	209	270↑29.5%	257↓5.0%	331↑28.9%	467↑40.8%
Total Assets	276	348↑26.1%	329↓5.5%	489↑48.5%	624↑27.7%
Total Current Liabilities	30	39↑29.3%	50↑26.8%	56↑11.5%	70↑25.2%
Total Liabilities	135	196↑45.5%	194↓1.3%	140↓28.0%	147↑5.2%
Total Equity	141	152↑7.7%	135↓11.0%	349↑158.1%	477↑36.8%
Total Debt	103	154↑50.1%	141↓8.4%	82↓41.9%	80↓2.7%
Net Debt	52	68↑31.0%	90↑32.6%	-21↓123.4%	-8↑63.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-112	-60↑47.0%	9↑114.8%	119↑1248.5%	50↓57.5%
Capital Expenditure	-14	-14↓3.0%	-5↑64.2%	-9↓72.2%	-23↓163.3%
Free Cash Flow	-126	-73↑41.7%	4↑105.2%	110↑2782.9%	28↓74.7%
Stock-Based Comp	3	5↑49.5%	6↑18.6%	14↑120.1%	20↑47.1%
Net Change in Cash	-5	35↑833.3%	-35↓199.3%	52↑247.3%	-16↓130.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance